Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
The diagnosis of Creutzfeldt-Jakob disease is based on clinical and
electroencephalographic criteria. Surrogate markers in cerebrospinal
fluid can also aid diagnosis. On page 577 Otto et al report that a
highly sensitive serum assay for brain specific S100 protein can be
used to distinguish Creutzfeldt-Jakob disease from other diseases which
cause dementia (sensitivity 77.8%, and specificity 81.1%).
New variant Creutzfeldt-Jakob disease is possibly related to
the causative agent of bovine spongiform encephalopathy. In view of the
public health implications, the accurate ascertainment of cases is
vital but difficult. On p 593 da Silva et al describe using single
photon emission computed tomography with HMPAO to identify two cases of
new variant Creutzfeldt-Jakob disease. They stress that the tomography
findings are not diagnostic, but that abnormalities particularly in the
setting of normal electroencephalography or cerebral magnetic resonance
imaging should raise the suspicion of new variant Creutzfeldt-Jakob
disease. Highly specialised "diagnostic" techniques can then be
targeted at these patients.